Neomass AAAC 3.0

The NeoMass AAAC 3.0 is an upgraded version of the NeoMass AAAC Plus kit. With no changes to the extraction process, the addition of Nucleoside and Lysophospholipid in the updated marker panel detects adenosine deaminase (ADA) deficiency and X-linked adrenoleukodystrophy (X-ALD) genetic disorders with higher sensitivity and specificity.

overview

Quantitative Analysis of;

15 Amino Acids
13 Acyl Carnitines
Argininosuccinic Acid (ASA)
Succinylacetone (SUAC)
Lysophospholipid
Nucleoside

Features

Screening of multiple disorders (> 50 Disorders) with single injection/single run protocol
Three levels of dried blood spot controls covering the clinically valid range
Simple four-step processing (Punch-Extract-Transfer-Analyze) without derivatization
No additional incubation or assay buffer is required for SUAC quantification
Internal standards validated for long-term stability
High throughput analysis, measuring each sample in 1.5 min with the shortest extraction time

Technical Specifications

Simple protein precipitation method with high recovery for all analytes including SUAC, Lysophospholipid and Nucleoside (Adenosine)

download Brochure

Neomass AAAC 3.0

overview

Features

Technical Specifications

request for quote